China Sky One Medical, Inc. has developed a nasal spray that treats rheumatic disease. The formulation, which includes naphazoline hydrochloride, chlorpheniramine maleate and benzalkonium bromide, is already readily available in China, but is manufactured by only five other companies. China Sky One has received approval to begin its own production of the spray. More details...

Stock Symbol: (AMEX: CSY)